Nuvation Bio to go public in combination with blank cheque firm Panacea

Preclinical-stage oncology focused company Nuvation Bio, will combine with Panacea Acquisition Corp., a special purpose acquisition company sponsored by EcoR1 Capital; CEO David Hung has…
Read More